Visiomed Group SA [ALVMG] vs Bonyf N.V [MLBON] Detailed Stock Comparison
Visiomed Group SA
Euronext
Loading...
Bonyf N.V
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Visiomed Group SA wins in 8 metrics, Bonyf N.V wins in 5 metrics, with 0 ties. Visiomed Group SA appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Visiomed Group SA | Bonyf N.V | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 57.80 | N/A | N/A |
| Price-to-Book Ratio | 2.10 | 17.50 | Visiomed Group SA |
| Debt-to-Equity Ratio | 32.03 | 0.00 | Bonyf N.V |
| PEG Ratio | 5.75 | N/A | N/A |
| EV/EBITDA | 29.71 | 0.00 | Bonyf N.V |
| Profit Margin (TTM) | 6.58% | 8.02% | Bonyf N.V |
| Operating Margin (TTM) | 6.76% | -11.98% | Visiomed Group SA |
| EBITDA Margin (TTM) | 6.76% | N/A | N/A |
| Return on Equity | 3.68% | -1.38% | Visiomed Group SA |
| Return on Assets (TTM) | 0.68% | -1.09% | Visiomed Group SA |
| Free Cash Flow (TTM) | $-1.50M | $56.95M | Bonyf N.V |
| 1-Year Return | 23.53% | -19.38% | Visiomed Group SA |
| Price-to-Sales Ratio (TTM) | 3.88 | 27.60 | Visiomed Group SA |
| Enterprise Value | $56.21M | $0 | Visiomed Group SA |
| EV/Revenue Ratio | 4.10 | 0.00 | Bonyf N.V |
| Revenue per Share (TTM) | $0 | N/A | N/A |
| Earnings per Share (Diluted) | $0.00 | $-1.78 | Visiomed Group SA |
| Beta (Stock Volatility) | -0.63 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Visiomed Group SA vs Bonyf N.V Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Visiomed Group SA | 1.45% | 5.00% | 10.53% | 16.67% | 0.00% | 23.53% |
| Bonyf N.V | 0.00% | 0.00% | 0.00% | -18.35% | -30.27% | -28.33% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Visiomed Group SA | 23.53% | -48.78% | -80.19% | -89.12% | -92.98% | -92.98% |
| Bonyf N.V | -19.38% | 7.50% | 3.20% | 3.20% | 3.20% | 3.20% |
Performance & Financial Health Analysis: Visiomed Group SA vs Bonyf N.V
| Metric | ALVMG | MLBON |
|---|---|---|
| Market Information | ||
| Market Cap | €53.17M | €7.77M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 500,329 | 1 |
| 90 Day Avg. Volume | 543,191 | 0 |
| Last Close | €0.21 | €12.90 |
| 52 Week Range | €0.15 - €0.25 | €12.90 - €19.50 |
| % from 52W High | -17.49% | -33.85% |
| All-Time High | €173.86 (Dec 15, 2014) | €19.50 (Feb 17, 2025) |
| % from All-Time High | -99.88% | -33.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.29% | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.08% |
| Operating Margin (TTM) | 0.07% | -0.12% |
| Return on Equity (TTM) | 0.04% | -0.01% |
| Debt to Equity (MRQ) | 32.03 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €0.08 | €0.74 |
| Cash per Share (MRQ) | €0.01 | N/A |
| Operating Cash Flow (TTM) | €1.11M | €56.95M |
| Levered Free Cash Flow (TTM) | €-488,000 | €-36,509 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Visiomed Group SA vs Bonyf N.V
| Metric | ALVMG | MLBON |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 57.80 | N/A |
| Forward P/E | 5.75 | N/A |
| PEG Ratio | 5.75 | N/A |
| Price to Sales (TTM) | 3.88 | 27.60 |
| Price to Book (MRQ) | 2.10 | 17.50 |
| Market Capitalization | ||
| Market Capitalization | €53.17M | €7.77M |
| Enterprise Value | €56.21M | €0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.10 | 0.00 |
| Enterprise to EBITDA | 29.71 | 0.00 |
| Risk & Other Metrics | ||
| Beta | -0.63 | N/A |
| Book Value per Share (MRQ) | €0.08 | €0.74 |
Financial Statements Comparison: Visiomed Group SA vs Bonyf N.V
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALVMG | MLBON |
|---|---|---|
| Revenue/Sales | N/A | €789,432 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | €789,432 |
| EBITDA | N/A | €789,432 |
| Pre-Tax Income | N/A | €789,432 |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | €789,432 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALVMG | MLBON |
|---|---|---|
| Cash & Equivalents | €2.97M | €16,301 |
| Total Current Assets | €5.28M | €1.42M |
| Total Current Liabilities | €3.38M | €287,755 |
| Long-Term Debt | €7.64M | €260,384 |
| Total Shareholders Equity | €24.75M | €433,967 |
| Retained Earnings | €902,000 | €144,167 |
| Property, Plant & Equipment | €7.30M | €13,146 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALVMG | MLBON |
|---|---|---|
| Operating Cash Flow | N/A | €236,514 |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | €236,514 |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALVMG | MLBON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 500,329 | 1 |
| Average Daily Volume (90 Day) | 543,191 | 0 |
| Shares Outstanding | 294.17M | 588,600 |
| Float Shares | N/A | N/A |
| % Held by Insiders | 0.00% | N/A |
| % Held by Institutions | 0.02% | N/A |
Dividend Analysis & Yield Comparison: Visiomed Group SA vs Bonyf N.V
| Metric | ALVMG | MLBON |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |